Jackie Tileston examines nondual mysticism, 5-MeO-DMT, clinical integration, and why psychedelic art should invite experience

Jackie Tileston discusses how nondual philosophy, mystical experience, clinical psychedelic practice, and art can inform one another. She describes the Penn Psychedelics Collaborative and its interdisciplinary teaching, argues that mystical experiences should not be excluded from psychedelic research, and distinguishes Buddhist, Advaita Vedanta, and Kashmir Shaiva frameworks. In her view, the metaphysical framework offered after a high-dose 5-MeO-DMT experience can shape whether it becomes an insight or an ontological crisis, making integration and appropriately experienced facilitators essential. She expects clinical 5-MeO-DMT to face a difficult rollout and supports low-dose, titrated protocols informed by underground practitioners. The conversation also considers neutral landing spaces that avoid imposing beliefs, creativity research, consciousness-first models, and neurophenomenology. Tileston criticizes psychedelic art that merely illustrates visions, favoring abstraction that invites viewers into direct experience.